Stock screenerAll disclosures →
EDGAR →
VKTX
Conviction 68HealthcareScan · Fri, Jun 26, 2026Bullish engulfing
VKTX$38.03+2.81%
ResistanceSupportVol 14Vol MA14 3.47M
Mar 27Apr 15May 4May 20Jun 9Jun 26
WSB mentions · 24h changelatest +33.33%· 4 mentions
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price38.03
Change+2.81%
Gap-1.72%
Rel volume4.01×
Avg volume3.03M
Avg $ vol99.83M
SMA 2031.22
SMA 5031.60
SMA 20032.66
Price vs 50+20.35%
Price vs 200+16.45%
MA stackmixed
50/200 cross—
Supertrendup · 32.18
RSI (14)73
MACD hist1.08
MACD crossbull · 7d
Stoch %K / %D88 / 89
ADX (14)25
+DI / −DI37 / 12
RSI divergenceBullish
MACD divergenceBullish
ATR %+4.93%
ADR %5.39%
52w high42.09
52w low23.09
From 52w high-9.65%
Above 52w low+64.70%
New 52w highNo
SqueezeOff
Bollinger width40.19%
%B1.04
Donchian pos88.45%
Donchian high39.45
Donchian low27.16
AVWAP (52w high)33.27
vs AVWAP high+14.32%
AVWAP (52w low)32.82
vs AVWAP low+15.87%
OBV trendUp
Chaikin MF (20)0.08
Today vs 20d4.01×
Avg vol (14d)3.47M
Avg vol (20d)3.03M
Avg $ vol (20d)99.83M
Market cap—
RS 3m (vs SPY)-0.38%
RS 6m (vs SPY)-2.73%
RS line new highNo
Trend template6/8
Technical rank76.0
1 week+25.18%
1 month+20.12%
3 months+11.04%
6 months+4.45%
1 year+40.38%
YTD+7.37%
P/E-11.94
P/B8.56
P/S—
P/FCF—
EPS-3.19
Div yield—
ROE-71.65%
ROA-59.13%
Debt/Eq—
Current5.72
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-227.05%
Price target92.91
Target upside151.21%
Analyst ratingBuy
Institutional73.75%
Ent. value4.18B
Revenue0
Net income-158.32M
Gross profit—
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out116.11M
Employees59
ListedWed, Apr 29, 2015
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction68 / 100
Pattern quality—
Tech rank76.0 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in VKTX
No recent disclosed trades by Congress in VKTX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in VKTX · 1 buy
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Chen Hubert C Chief Medical Officer · Stock Option (Right to Buy) · 2026-06-01 | Grant | 190K | $0 | 2026-06-01 | 2026-06-03 |
SEC filings
EDGAR filings in VKTX
No recent SEC filings on file for VKTX.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.